Breaking News Instant updates and real-time market news.

ASB

Associated Banc-Corp

$23.43 /

-0.06 (-0.26%)

05:24
03/21/22
03/21
05:24
03/21/22
05:24

Associated Banc-Corp upgraded to Overweight from Equal Weight at Wells Fargo

Wells Fargo analyst Jared Shaw upgraded Associated Banc-Corp to Overweight from Equal Weight with a $28 price target.

  • 26

    Apr

OTHER BREAKING NEWS FROM THE FLY

Initiation
Oak Street Health resumed with an Outperform at Bernstein » 20:20
05/26/22
05/26
20:20
05/26/22
20:20
OSH

Oak Street Health

$18.29 /

+0.87 (+4.99%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSH Oak Street Health
$18.29 /

+0.87 (+4.99%)

OSH Oak Street Health
$18.29 /

+0.87 (+4.99%)

16:12 Today Stifel
Oak Street Health initiated with a Buy at Stifel
04/20/22 UBS
Oak Street Health initiated with a Neutral at UBS
04/19/22 Barclays
Oak Street Health price target raised to $31 from $27 at Barclays
03/29/22 Guggenheim
Oak Street Health initiated with a Neutral at Guggenheim
OSH Oak Street Health
$18.29 /

+0.87 (+4.99%)

  • 27
    May
OSH Oak Street Health
$18.29 /

+0.87 (+4.99%)

OSH Oak Street Health
$18.29 /

+0.87 (+4.99%)

Downgrade
UnitedHealth downgraded to Market Perform at Bernstein on valuation » 20:16
05/26/22
05/26
20:16
05/26/22
20:16
UNH

UnitedHealth

$502.40 /

+4.29 (+0.86%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

16:45 Today Bernstein
UnitedHealth downgraded to Market Perform from Outperform at Bernstein
05/11/22 Citi
MultiPlan price target raised to $6.50 from $6 at Citi
04/26/22 Piper Sandler
Piper 'incrementally confident' Change, UNH will prevail in August
04/25/22 Deutsche Bank
LHC Group downgraded to Hold from Buy at Deutsche Bank
UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

UNH UnitedHealth
$502.40 /

+4.29 (+0.86%)

Initiation
Humana resumed with a Market Perform at Bernstein » 20:12
05/26/22
05/26
20:12
05/26/22
20:12
HUM

Humana

$452.22 /

+7.33 (+1.65%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$452.22 /

+7.33 (+1.65%)

HUM Humana
$452.22 /

+7.33 (+1.65%)

04/28/22 Wells Fargo
Humana price target raised to $512 from $491 at Wells Fargo
04/13/22 UBS
Humana upgraded to Buy from Neutral at UBS
04/07/22 Truist
Humana price target raised to $490 from $460 at Truist
02/03/22 Deutsche Bank
Humana price target raised to $435 from $418 at Deutsche Bank
HUM Humana
$452.22 /

+7.33 (+1.65%)

HUM Humana
$452.22 /

+7.33 (+1.65%)

HUM Humana
$452.22 /

+7.33 (+1.65%)

HUM Humana
$452.22 /

+7.33 (+1.65%)

Upgrade
HCA Healthcare upgraded to Outperform from Market Perform at Bernstein » 20:10
05/26/22
05/26
20:10
05/26/22
20:10
HCA

HCA Healthcare

$211.86 /

+6.12 (+2.97%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$211.86 /

+6.12 (+2.97%)

HCA HCA Healthcare
$211.86 /

+6.12 (+2.97%)

16:53 Today Bernstein
HCA Healthcare upgraded to Outperform from Market Perform at Bernstein
05/03/22 Mizuho
HCA Healthcare price target lowered to $260 from $290 at Mizuho
04/26/22 BMO Capital
HCA Healthcare price target lowered to $240 from $275 at BMO Capital
04/26/22 UBS
HCA Healthcare price target lowered to $241 from $289 at UBS
HCA HCA Healthcare
$211.86 /

+6.12 (+2.97%)

HCA HCA Healthcare
$211.86 /

+6.12 (+2.97%)

Hot Stocks
Cathay General adopts new buyback program for up to $125M » 20:04
05/26/22
05/26
20:04
05/26/22
20:04
CATY

Cathay General

$40.00 /

+0.965 (+2.47%)

Cathay General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CATY Cathay General
$40.00 /

+0.965 (+2.47%)

01/31/22 Wedbush
Cathay General price target raised to $55 from $50 at Wedbush
08/30/21 Truist
Cathay General price target raised to $44 from $40 at Truist
06/21/21 Truist
Cathay General assumed with a Hold at Truist
CATY Cathay General
$40.00 /

+0.965 (+2.47%)

CATY Cathay General
$40.00 /

+0.965 (+2.47%)

Downgrade
CVS Health downgraded to Market Perform from Outperform at Bernstein » 20:03
05/26/22
05/26
20:03
05/26/22
20:03
CVS

CVS Health

$97.80 /

+0.68 (+0.70%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$97.80 /

+0.68 (+0.70%)

CVS CVS Health
$97.80 /

+0.68 (+0.70%)

16:45 Today Bernstein
CVS Health downgraded to Market Perform from Outperform at Bernstein
09:42 Today Oppenheimer
Oppenheimer continues to favor Teladoc, new policies positive for telehealth
05/05/22 Deutsche Bank
CVS Health price target raised to $113 from $110 at Deutsche Bank
04/25/22 Craig-Hallum
Identiv initiated with a Buy at Craig-Hallum
CVS CVS Health
$97.80 /

+0.68 (+0.70%)

CVS CVS Health
$97.80 /

+0.68 (+0.70%)

CVS CVS Health
$97.80 /

+0.68 (+0.70%)

CVS CVS Health
$97.80 /

+0.68 (+0.70%)

Initiation
Cigna resumed with a Market Perform at Bernstein » 19:59
05/26/22
05/26
19:59
05/26/22
19:59
CI

Cigna

$268.88 /

+3.04 (+1.14%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$268.88 /

+3.04 (+1.14%)

CI Cigna
$268.88 /

+3.04 (+1.14%)

06:05 Today BofA
Cigna upgraded to Neutral from Underperform at BofA
05/23/22 Barclays
Cigna price target raised to $310 from $275 at Barclays
05/16/22 JPMorgan
Cigna upgraded to Overweight from Neutral at JPMorgan
05/10/22 Raymond James
Cigna price target raised to $300 from $275 at Raymond James
CI Cigna
$268.88 /

+3.04 (+1.14%)

CI Cigna
$268.88 /

+3.04 (+1.14%)

CI Cigna
$268.88 /

+3.04 (+1.14%)

CI Cigna
$268.88 /

+3.04 (+1.14%)

Initiation
Centene resumed with an Outperform at Bernstein » 19:58
05/26/22
05/26
19:58
05/26/22
19:58
CNC

Centene

$81.77 /

-3.53 (-4.14%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNC Centene
$81.77 /

-3.53 (-4.14%)

CNC Centene
$81.77 /

-3.53 (-4.14%)

06:07 Today BofA
Centene downgraded to Neutral from Buy at BofA
03/29/22 Deutsche Bank
CVS Health downgraded to Hold from Buy at Deutsche Bank
03/23/22 BTIG
Exagen price target lowered to $15 from $20 at BTIG
03/23/22 Jefferies
Centene CEO pick may spur some negative stock reaction, says Jefferies
CNC Centene
$81.77 /

-3.53 (-4.14%)

CNC Centene
$81.77 /

-3.53 (-4.14%)

CNC Centene
$81.77 /

-3.53 (-4.14%)

CNC Centene
$81.77 /

-3.53 (-4.14%)

Initiation
Anthem resumed with an Outperform at Bernstein » 19:57
05/26/22
05/26
19:57
05/26/22
19:57
ANTM

Anthem

$512.85 /

+7.665 (+1.52%)

Bernstein analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$512.85 /

+7.665 (+1.52%)

ANTM Anthem
$512.85 /

+7.665 (+1.52%)

05/25/22 Wells Fargo
Anthem price target lowered to $580 from $586 at Wells Fargo
05/04/22 Mizuho
Anthem price target raised to $545 from $510 at Mizuho
04/25/22 BMO Capital
Anthem price target raised to $625 from $540 at BMO Capital
04/22/22 Wells Fargo
Anthem price target raised to $586 at Wells Fargo
ANTM Anthem
$512.85 /

+7.665 (+1.52%)

ANTM Anthem
$512.85 /

+7.665 (+1.52%)

ANTM Anthem
$512.85 /

+7.665 (+1.52%)

Hot Stocks
Avis Budget chairman buys $4.9M in common stock » 19:13
05/26/22
05/26
19:13
05/26/22
19:13
CAR

Avis Budget

$185.03 /

+6.06 (+3.39%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

05/04/22 Deutsche Bank
Avis Budget price target raised to $238 from $193 at Deutsche Bank
04/26/22 Deutsche Bank
Hertz named short-term buy idea at Deutsche Bank
04/20/22 Barclays
Barclays upgrades Avis to neutral on 'constructive' rental stance
04/20/22 Barclays
Avis Budget upgraded to Equal Weight from Underweight at Barclays
CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

Hot Stocks
Myriad Genetics to present multiple genetic studies in cancer treatment at ASCO » 19:04
05/26/22
05/26
19:04
05/26/22
19:04
MYGN

Myriad Genetics

$21.15 /

-0.05 (-0.24%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

Earnings
Taro Pharmaceutical reports Q4 EPS 73c vs. (78c) last year » 19:01
05/26/22
05/26
19:01
05/26/22
19:01
TARO

Taro Pharmaceutical

$34.54 /

-2.25 (-6.12%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TARO Taro Pharmaceutical
$34.54 /

-2.25 (-6.12%)

TARO Taro Pharmaceutical
$34.54 /

-2.25 (-6.12%)

01/31/22 H.C. Wainwright
Taro Pharmaceutical price target lowered to $73 from $75 at H.C. Wainwright
01/18/22 H.C. Wainwright
Taro Pharmaceutical price target lowered to $75 from $82 at H.C. Wainwright
07/28/21 H.C. Wainwright
Taro Pharmaceutical price target raised to $82 from $80 at H.C. Wainwright
Hot Stocks
Biomea Fusion to present new preclinical data on BMF-219 at ASCO » 19:00
05/26/22
05/26
19:00
05/26/22
19:00
BMEA

Biomea Fusion

$5.20 /

+0.03 (+0.58%)

Biomea Fusion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

05/17/22 Piper Sandler
Biomea Fusion price target lowered to $25 from $27 at Piper Sandler
01/12/22 H.C. Wainwright
Biomea Fusion initiated with a Buy at H.C. Wainwright
12/16/21 Oppenheimer
Biomea Fusion initiated with an Outperform at Oppenheimer
BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

Recommendations
Equinix price target lowered to $770 from $825 at BMO Capital » 18:57
05/26/22
05/26
18:57
05/26/22
18:57
EQIX

Equinix

$669.92 /

-18.56 (-2.70%)

BMO Capital analyst Ari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$669.92 /

-18.56 (-2.70%)

EQIX Equinix
$669.92 /

-18.56 (-2.70%)

05/24/22 Stifel
Equinix added to 'Select List' on selloff at Stifel
04/29/22 JPMorgan
Equinix price target raised to $880 from $860 at JPMorgan
04/25/22 Credit Suisse
Equinix price target raised to $714 from $673 at Credit Suisse
04/08/22 Deutsche Bank
Equinix price target raised to $785 from $780 at Deutsche Bank
EQIX Equinix
$669.92 /

-18.56 (-2.70%)

EQIX Equinix
$669.92 /

-18.56 (-2.70%)

Hot Stocks
Mereo BioPharma to present updated Phase 1b/2 data on Etigilimab and Nivolumab » 18:57
05/26/22
05/26
18:57
05/26/22
18:57
MREO

Mereo BioPharma

/

+

Mereo BioPharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MREO Mereo BioPharma
/

+

Hot Stocks
Affimed to present on three AFM24 clinical trial designs at ASCO 2022 » 18:55
05/26/22
05/26
18:55
05/26/22
18:55
AFMD

Affimed

$3.15 /

-0.02 (-0.63%)

Affimed announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFMD Affimed
$3.15 /

-0.02 (-0.63%)

AFMD Affimed
$3.15 /

-0.02 (-0.63%)

04/11/22 Cantor Fitzgerald
Affimed AFM13 + NK combination data exceed expectations, says Cantor Fitzgerald
03/30/22 Piper Sandler
Affimed initiated with an Overweight at Piper Sandler
02/23/22 Cantor Fitzgerald
Affimed initiated with an Overweight at Cantor Fitzgerald
02/23/22 Cantor Fitzgerald
Affimed initiated with an Overweight at Cantor Fitzgerald
  • 13
    Apr
AFMD Affimed
$3.15 /

-0.02 (-0.63%)

Hot Stocks
Oncternal Therapeutics presents interim data for Zilovertamab+Ibrutinib at ASCO » 18:51
05/26/22
05/26
18:51
05/26/22
18:51
ONCT

Oncternal Therapeutics

/

+

Oncternal Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCT Oncternal Therapeutics
/

+

ONCT Oncternal Therapeutics
/

+

05/10/22 Maxim
Oncternal Therapeutics initiated with a Buy at Maxim
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
ONCT Oncternal Therapeutics
/

+

ONCT Oncternal Therapeutics
/

+

Hot Stocks
Puma Biotechnology to present two abstracts on neratinib at ASCO Meeting » 18:49
05/26/22
05/26
18:49
05/26/22
18:49
PBYI

Puma Biotechnology

$1.95 /

+0.035 (+1.83%)

Puma Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

Hot Stocks
Invitae to present eight studies at ASCO » 18:48
05/26/22
05/26
18:48
05/26/22
18:48
NVTA

Invitae

$3.50 /

+0.095 (+2.79%)

Invitae "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$3.50 /

+0.095 (+2.79%)

NVTA Invitae
$3.50 /

+0.095 (+2.79%)

05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
10/14/21 Cowen
Invitae coverage transferred at Cowen
NVTA Invitae
$3.50 /

+0.095 (+2.79%)

NVTA Invitae
$3.50 /

+0.095 (+2.79%)

Hot Stocks
Arbutus Biopharma to present data from preclinical study of PD-L1 inhibitor » 18:47
05/26/22
05/26
18:47
05/26/22
18:47
ABUS

Arbutus Biopharma

$2.31 /

+0.055 (+2.44%)

Arbutus Biopharma's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

03/14/22 H.C. Wainwright
Arbutus Biopharma price target raised to $8.50 from $8 at H.C. Wainwright
03/04/22 Chardan
Arbutus Biopharma price target raised to $6 from $5.50 at Chardan
12/29/21 Jefferies
Arbutus Biopharma assumed with a Hold at Jefferies
12/13/21 H.C. Wainwright
H.C. Wainwright sees Arbutus' $300M-plus licensing deal for AB-729 as low-risk
ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

Hot Stocks
Elevation Oncology to present initial Seribantumab data at ASCO » 18:46
05/26/22
05/26
18:46
05/26/22
18:46
ELEV

Elevation Oncology

$3.35 /

-0.62 (-15.64%)

Elevation Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

05/06/22 Wedbush
Elevation Oncology price target lowered to $15 from $21 at Wedbush
03/04/22 Wedbush
Elevation Oncology price target lowered to $21 from $27 at Wedbush
12/23/21
Fly Intel: Top five analyst initiations
12/23/21 H.C. Wainwright
Elevation Oncology initiated with a Buy at H.C. Wainwright
ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

  • 25
    Jun
Hot Stocks
PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO » 18:42
05/26/22
05/26
18:42
05/26/22
18:42
PDSB

PDS Biotechnology

$4.99 /

-0.06 (-1.19%)

PDS Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

05/13/22 Alliance Global Partners
PDS Biotechnology price target lowered to $16 from $18 at Alliance Global Partners
10/21/21 H.C. Wainwright
H.C. Wainwright says PDS Biotechnology temporary hold shouldn't spark concerns
08/12/21 H.C. Wainwright
PDS Biotechnology price target lowered to $15 from $20 at H.C. Wainwright
06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

  • 15
    Jun
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

Hot Stocks
Gracell to present updated clinical data on GC012F in multiple myeloma » 18:40
05/26/22
05/26
18:40
05/26/22
18:40
GRCL

Gracell

$3.00 /

-0.045 (-1.48%)

Gracell Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRCL Gracell
$3.00 /

-0.045 (-1.48%)

GRCL Gracell
$3.00 /

-0.045 (-1.48%)

04/04/22 BTIG
BTIG starts Gracell at Buy, sees stock trading at 'significant discount'
04/04/22 BTIG
Gracell initiated with a Buy at BTIG
03/14/22 Piper Sandler
Gracell price target lowered to $25 from $40 at Piper Sandler
06/14/21 Piper Sandler
Gracell plans to expand GC012F's clinical profile, says Piper Sandler
GRCL Gracell
$3.00 /

-0.045 (-1.48%)

GRCL Gracell
$3.00 /

-0.045 (-1.48%)

Hot Stocks
SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO » 18:39
05/26/22
05/26
18:39
05/26/22
18:39
SWTX

SpringsWorks Therapeutics

$30.81 /

-1.76 (-5.40%)

, GSK

GlaxoSmithKline

$44.41 /

-0.57 (-1.27%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
03/01/22 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright
10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

05/19/22 Deutsche Bank
GlaxoSmithKline price target raised to 1,750 GBp at Deutsche Bank
05/17/22 Roth Capital
Ideaya Biosciences price target raised to $46 from $42 at Roth Capital
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
04/29/22 Barclays
GlaxoSmithKline price target raised to 1,800 GBp from 1,775 GBp at Barclays
SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

Hot Stocks
Alaunos Therapeutics to present data on TCR-T Library Phase 1/2 trial » 18:36
05/26/22
05/26
18:36
05/26/22
18:36
TCRT

Alaunos Therapeutics

/

+

Alaunos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRT Alaunos Therapeutics
/

+

TCRT Alaunos Therapeutics
/

+

05/04/22 Wells Fargo
Wells Fargo upgrades Alaunos Therapeutics to Overweight with $3 price target
05/04/22 Wells Fargo
Alaunos upgraded to Overweight from Equal Weight at Wells Fargo
TCRT Alaunos Therapeutics
/

+

TCRT Alaunos Therapeutics
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.